Federation Des Caisses Desjardins Du Quebec Jazz Pharmaceuticals PLC Transaction History
Federation Des Caisses Desjardins Du Quebec
- $23.7 Billion
- Q3 2025
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 4,445 shares of JAZZ stock, worth $627,056. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,445
Previous 485
816.49%
Holding current value
$627,056
Previous $51,000
1047.06%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding JAZZ
# of Institutions
572Shares Held
61.9MCall Options Held
856KPut Options Held
178K-
Black Rock Inc. New York, NY6.15MShares$867 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.91MShares$833 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.84MShares$400 Million0.08% of portfolio
-
Capital World Investors Los Angeles, CA2.55MShares$360 Million0.05% of portfolio
-
Lsv Asset Management Chicago, IL2.51MShares$354 Million0.73% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $8.84B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...